Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$384.32

+16.52 (+4.49%)

As of Feb 12, 6:29 PM ET ·

Income Statement

	FY 2026	FY 2026	FY 2025	FY 2025	FY 2025
Revenue	36.51B	36.51B	32.67B	32.67B	536.40B
Net Income	7.66B	7.66B	6.17B	6.17B	9.60B
EPS	—	—	—	—	—
Profit Margin	21.0%	21.0%	19.9%	19.9%	1.8%
Rev Growth	+11.8%	+11.8%	+11.8%	+11.8%	+23.2%

Balance Sheet

	FY 2026	FY 2026	FY 2025	FY 2025	FY 2025
Total Debt	89.31B	89.31B	89.31B	89.31B	58.51B
Total Equity	14.16B	14.16B	14.16B	14.16B	122.00B
D/E Ratio	6.31	6.31	6.31	6.31	0.48

Cash Flow

	FY 2026	FY 2026	FY 2025	FY 2025	FY 2025
EBITDA	9.64B	9.64B	8.20B	8.20B	15.58B
Free Cash Flow	—	—	—	—	7.91B